Published in J Clin Endocrinol Metab on August 14, 2007
Interdomain movements in metabotropic glutamate receptor activation. Proc Natl Acad Sci U S A (2011) 1.07
Calcium sensing receptor mutations implicated in pancreatitis and idiopathic epilepsy syndrome disrupt an arginine-rich retention motif. Cell Physiol Biochem (2010) 0.87
Large putative PEST-like sequence motif at the carboxyl tail of human calcium receptor directs lysosomal degradation and regulates cell surface receptor level. J Biol Chem (2011) 0.78
Multiple endocrine neoplasia phenocopy revealed as a co-occurring neuroendocrine tumor and familial hypocalciuric hypercalcemia type 3. Clin Case Rep (2016) 0.75
Identification and Functional Characterization of a Calcium-Sensing Receptor Mutation in an Infant with Familial Hypocalciuric Hypercalcemia. J Clin Res Pediatr Endocrinol (2016) 0.75
A novel CaSR mutation presenting as a severe case of neonatal familial hypocalciuric hypercalcemia. Int J Pediatr Endocrinol (2012) 0.75
Familial hypocalciuric hypercalcemia: new mutation in the CASR gene converting valine 697 to methionine. Eur J Pediatr (2011) 0.75
Parathyroid hormone-dependent hypercalcemia. Wien Klin Wochenschr (2009) 0.75
Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ (2012) 5.63
Fracture risk and zoledronic acid therapy in men with osteoporosis. N Engl J Med (2012) 3.51
Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 3.11
Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA (2008) 2.52
The effects of calcium supplementation on verified coronary heart disease hospitalization and death in postmenopausal women: a collaborative meta-analysis of randomized controlled trials. J Bone Miner Res (2015) 2.49
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev (2010) 2.38
Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res (2011) 2.30
Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA (2004) 2.20
Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res (2003) 2.15
Fracture risk in patients with celiac Disease, Crohn's disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark. Am J Epidemiol (2002) 2.05
Differing effects of PTH 1-34, PTH 1-84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18-month open-labeled observational study using HR-pQCT. J Bone Miner Res (2013) 1.78
Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977-2001. J Bone Miner Res (2009) 1.76
Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients. Thyroid (2002) 1.66
Fracture risk associated with use of antiepileptic drugs. Epilepsia (2004) 1.55
Changes in 3-dimensional bone structure indices in hypoparathyroid patients treated with PTH(1-84): a randomized controlled study. J Bone Miner Res (2012) 1.54
[Vitamin D deficiency. Definition and prevalence in Denmark]. Ugeskr Laeger (2005) 1.53
The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism. Diabetes Care (2006) 1.52
Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial. Arthritis Rheum (2008) 1.51
High-dose treatment with vitamin A analogues and risk of fractures. Arch Dermatol (2010) 1.50
Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J Hypertens (2006) 1.48
Chronic diseases in elderly men: underreporting and underdiagnosis. Age Ageing (2011) 1.48
The relationship between health-related quality of life, obesity and testosterone levels in older men. Age Ageing (2013) 1.47
Fracture risk in users of oral anticoagulants: a nationwide case-control study. Int J Cardiol (2006) 1.46
Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark. Osteoporos Int (2004) 1.43
Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J Clin Endocrinol Metab (2012) 1.42
The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study. J Bone Miner Res (2011) 1.42
Cardiovascular events before and after surgery for primary hyperparathyroidism. World J Surg (2003) 1.40
[Teriparatide (human recombinant 1-34 parathyroid hormone)--a new treatment regimen for severe osteoporosis]. Ugeskr Laeger (2004) 1.40
Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes. Calcif Tissue Int (2008) 1.40
[Denosumab--a new efficient osteoporosis therapy]. Ugeskr Laeger (2011) 1.39
Risk assessment tools to identify women with increased risk of osteoporotic fracture: complexity or simplicity? A systematic review. J Bone Miner Res (2013) 1.38
Hyperthyroidism, bone mineral, and fracture risk--a meta-analysis. Thyroid (2003) 1.38
Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate. J Clin Endocrinol Metab (2007) 1.32
Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods. Clin Endocrinol (Oxf) (2008) 1.31
Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders--a nationwide register study. Int J Eat Disord (2002) 1.27
Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. J Bone Miner Res (2006) 1.24
Nephrolithiasis and renal calcifications in primary hyperparathyroidism. J Clin Endocrinol Metab (2011) 1.24
Suppression of endogenous testosterone production attenuates the response to strength training: a randomized, placebo-controlled, and blinded intervention study. Am J Physiol Endocrinol Metab (2006) 1.24
Patient education in groups increases knowledge of osteoporosis and adherence to treatment: a two-year randomized controlled trial. Patient Educ Couns (2010) 1.22
Fracture risk associated with parkinsonism and anti-Parkinson drugs. Calcif Tissue Int (2007) 1.22
Gastric and esophagus events before and during treatment of osteoporosis. Calcif Tissue Int (2009) 1.22
Visceral and subcutaneous adipose tissue assessed by magnetic resonance imaging in relation to circulating androgens, sex hormone-binding globulin, and luteinizing hormone in young men. J Clin Endocrinol Metab (2007) 1.21
Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo-controlled trial. J Clin Endocrinol Metab (2008) 1.20
Hypertension is a risk factor for fractures. Calcif Tissue Int (2008) 1.19
Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study. Arch Intern Med (2004) 1.18
Syndecan-1 and angiogenic cytokines in multiple myeloma: correlation with bone marrow angiogenesis and survival. Br J Haematol (2005) 1.18
Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study. BMJ (2002) 1.17
Has mortality after a hip fracture increased? J Am Geriatr Soc (2007) 1.16
Sequential treatment of severe postmenopausal osteoporosis after teriparatide: final results of the randomized, controlled European Study of Forsteo (EUROFORS). J Bone Miner Res (2009) 1.16
Vitamin D and calcium supplementation prevents severe falls in elderly community-dwelling women: a pragmatic population-based 3-year intervention study. Aging Clin Exp Res (2005) 1.16
Vitamin D status in Greenland is influenced by diet and ethnicity: a population-based survey in an Arctic society in transition. Br J Nutr (2012) 1.14
Autosomal dominant osteopetrosis revisited: lessons from recent studies. Eur J Endocrinol (2013) 1.12
Selective serotonin reuptake inhibitors and other antidepressants and risk of fracture. Calcif Tissue Int (2008) 1.10
Increased plasma concentrations of vitamin D metabolites and vitamin D binding protein in women using hormonal contraceptives: a cross-sectional study. Nutrients (2013) 1.09
Effects on bone geometry, density, and microarchitecture in the distal radius but not the tibia in women with primary hyperparathyroidism: A case-control study using HR-pQCT. J Bone Miner Res (2010) 1.08
Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study. Bone (2007) 1.07
Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5. J Bone Miner Res (2011) 1.06
Intake of vitamin D and risk of breast cancer--a meta-analysis. J Steroid Biochem Mol Biol (2008) 1.06
PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment. J Bone Miner Res (2013) 1.06
A randomized trial of laypersons' perception of the benefit of osteoporosis therapy: number needed to treat versus postponement of hip fracture. Clin Ther (2003) 1.06
Smoking as a risk factor for Graves' disease, toxic nodular goiter, and autoimmune hypothyroidism. Thyroid (2002) 1.05
Birth prevalence and mutation spectrum in danish patients with autosomal recessive albinism. Invest Ophthalmol Vis Sci (2008) 1.05
Trends in incidence and mortality in the hospital diagnosis of atrial fibrillation or flutter in Denmark, 1980-1999. Int J Cardiol (2005) 1.04
Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism. BMJ (2003) 1.03
Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: results from a randomized controlled study with bumetanide. J Bone Miner Res (2005) 1.03
Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women. J Bone Miner Res (2004) 1.03
Osteoarthritis and risk of fractures. Calcif Tissue Int (2009) 1.02
Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev (2009) 1.01
Skin barrier abnormality caused by filaggrin (FLG) mutations is associated with increased serum 25-hydroxyvitamin D concentrations. J Allergy Clin Immunol (2012) 1.00
Incidence and prevalence of nutritional and hereditary rickets in southern Denmark. Eur J Endocrinol (2008) 1.00
Fracture risk in Danish men with prostate cancer: a nationwide register study. BJU Int (2007) 0.99
Postsurgical hypoparathyroidism--risk of fractures, psychiatric diseases, cancer, cataract, and infections. J Bone Miner Res (2014) 0.99
Hip fracture risk in statin users--a population-based Danish case-control study. Osteoporos Int (2004) 0.99
Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial. J Clin Endocrinol Metab (2014) 0.98
Decreased fracture risk in users of organic nitrates: a nationwide case-control study. J Bone Miner Res (2006) 0.98
Patients with high-bone-mass phenotype owing to Lrp5-T253I mutation have low plasma levels of serotonin. J Bone Miner Res (2010) 0.98
Single-nucleotide polymorphisms in the P2X7 receptor gene are associated with post-menopausal bone loss and vertebral fractures. Eur J Hum Genet (2012) 0.98
Determinants of plasma PTH and their implication for defining a reference interval. Clin Endocrinol (Oxf) (2011) 0.97
Fracture risk in perimenopausal women treated with beta-blockers. Calcif Tissue Int (2004) 0.96
Fractures in patients with primary hyperparathyroidism: nationwide follow-up study of 1201 patients. World J Surg (2003) 0.96
Simvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trial. Int J Endocrinol (2009) 0.96
Maxillary distraction osteogenesis in a patient with pycnodysostosis: a case report. J Oral Maxillofac Surg (2004) 0.96
Are antiresorptive drugs effective against fractures in patients with diabetes? Calcif Tissue Int (2010) 0.95
High-throughput liquid-liquid extraction and LCMSMS assay for determination of circulating 25(OH) vitamin D3 and D2 in the routine clinical laboratory. Clin Chim Acta (2009) 0.95
Bone microarchitecture and estimated strength in 499 adult Danish women and men: a cross-sectional, population-based high-resolution peripheral quantitative computed tomographic study on peak bone structure. Calcif Tissue Int (2013) 0.94
The effects of depot medroxyprogesterone acetate and intrauterine device use on fracture risk in Danish women. Contraception (2008) 0.94